Responses
Inflammatory bowel disease
5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 18 April 2016
- Published on: 18 April 20165-Aminosalicylate use and colorectal cancer risk in inflammatory bowel diseaseShow More
Dear Editor,
We read this article with great interest. Thanks to author for submitting an interesting article. If the patients were on prednisolone or other immunosuppressive drugs then possible effects on CRC risk may be influenced by use of glucocorticoids or immunosuppressant. Question is which drugs really reduce the risk of colorectal cancer risk? As any effect of 5-ASA therapy on the risk of CRC could be me...
Conflict of Interest:
None declared.